ICD-10: O43.813
Placental infarction, third trimester
Additional Information
Treatment Guidelines
Placental infarction, particularly in the third trimester, is a condition characterized by localized areas of ischemic necrosis in the placenta, which can lead to various complications for both the mother and the fetus. The ICD-10 code O43.813 specifically refers to this condition, and understanding the standard treatment approaches is crucial for managing the health of both the mother and the developing fetus.
Understanding Placental Infarction
Placental infarction occurs when blood flow to a portion of the placenta is compromised, leading to tissue death. This can result from various factors, including maternal hypertension, diabetes, or vascular disorders. In the third trimester, the implications of placental infarction can be particularly severe, as it may affect fetal growth and well-being.
Standard Treatment Approaches
1. Monitoring and Assessment
- Ultrasound Evaluation: Regular ultrasound examinations are essential to assess the extent of the infarction and monitor fetal growth and well-being. Doppler studies may also be employed to evaluate blood flow in the umbilical artery and assess placental function[1].
- Fetal Heart Rate Monitoring: Continuous monitoring of the fetal heart rate can help detect any signs of distress that may arise due to placental insufficiency[1].
2. Management of Underlying Conditions
- Control of Maternal Health Issues: Effective management of any underlying maternal conditions, such as hypertension or diabetes, is critical. This may involve medication adjustments, lifestyle changes, and regular follow-ups with healthcare providers[2].
- Nutritional Support: Ensuring that the mother has a balanced diet rich in essential nutrients can help support placental health and fetal development[2].
3. Medical Interventions
- Corticosteroids: In cases where preterm delivery is anticipated, corticosteroids may be administered to accelerate fetal lung maturity and reduce the risk of complications associated with prematurity[3].
- Anticoagulation Therapy: If placental infarction is associated with thrombophilia or other clotting disorders, anticoagulation therapy may be considered to improve placental blood flow[3].
4. Delivery Planning
- Timing of Delivery: The timing of delivery may be adjusted based on the severity of the placental infarction and the health of the fetus. In some cases, early delivery may be necessary to prevent further complications[4].
- Mode of Delivery: The mode of delivery (vaginal vs. cesarean) will depend on the clinical scenario, including the fetal condition and maternal health status. A multidisciplinary team approach is often required to make these decisions[4].
5. Postpartum Care
- Monitoring for Complications: After delivery, both the mother and the newborn should be monitored for any complications arising from placental insufficiency, such as growth restrictions or developmental delays in the infant[5].
- Psychosocial Support: Providing emotional and psychological support to the mother is important, as experiencing complications during pregnancy can lead to anxiety and stress[5].
Conclusion
The management of placental infarction in the third trimester requires a comprehensive approach that includes careful monitoring, addressing underlying health issues, and planning for delivery. By employing these standard treatment strategies, healthcare providers can help mitigate risks and promote better outcomes for both the mother and the fetus. Continuous research and clinical guidelines will further refine these approaches, ensuring that they remain effective and evidence-based.
References
- Identifying Pregnant and Postpartum Beneficiaries in ...
- Severity of Anemia During Pregnancy and Adverse ...
- Preventive Care Services: Diagnosis Codes
- Association between uterine artery embolization for ...
- Sixth International Conference on Fetal Growth
Description
Placental infarction is a significant condition that can arise during pregnancy, particularly in the third trimester. The ICD-10 code O43.813 specifically designates "Placental infarction, third trimester," which is crucial for accurate medical coding and billing, as well as for clinical documentation.
Clinical Description of Placental Infarction
Definition
Placental infarction refers to localized areas of ischemic necrosis within the placenta, resulting from inadequate blood supply. This condition can lead to various complications for both the mother and the fetus, including impaired fetal growth, preterm birth, and potential stillbirth.
Etiology
The causes of placental infarction can be multifactorial, including:
- Maternal Conditions: Hypertension, diabetes, and autoimmune disorders can compromise placental blood flow.
- Vascular Issues: Thrombosis or embolism in the maternal or fetal circulation can lead to infarction.
- Infections: Certain infections may also contribute to placental dysfunction and infarction.
Symptoms
Placental infarction may not always present with overt symptoms, but potential signs can include:
- Abnormal fetal heart rate patterns
- Decreased fetal movement
- Signs of maternal distress, such as abdominal pain or bleeding
Diagnosis
Diagnosis typically involves:
- Ultrasound Imaging: This is the primary tool for identifying placental abnormalities, including infarction. Doppler studies may also assess blood flow.
- Clinical Evaluation: Monitoring maternal and fetal health through regular check-ups is essential, especially in high-risk pregnancies.
ICD-10 Code O43.813
Code Details
- Code: O43.813
- Category: O43 - Placental disorders
- Specificity: This code is used specifically for cases of placental infarction occurring in the third trimester of pregnancy, which is defined as weeks 28 to 40 of gestation.
Clinical Implications
The use of this code is vital for:
- Clinical Management: It helps healthcare providers identify and manage the risks associated with placental infarction.
- Research and Data Collection: Accurate coding contributes to epidemiological studies and the understanding of pregnancy complications.
- Insurance and Billing: Proper coding ensures that healthcare providers receive appropriate reimbursement for the care provided.
Conclusion
Understanding the clinical implications and coding specifics of placental infarction, particularly under the ICD-10 code O43.813, is essential for healthcare professionals involved in maternal-fetal medicine. Early identification and management of this condition can significantly impact maternal and fetal outcomes, making it a critical area of focus during prenatal care. Regular monitoring and appropriate interventions are key to mitigating the risks associated with placental infarction.
Clinical Information
Placental infarction, particularly in the third trimester, is a significant condition that can impact both maternal and fetal health. Understanding its clinical presentation, signs, symptoms, and patient characteristics is crucial for timely diagnosis and management.
Clinical Presentation
Placental infarction refers to localized areas of ischemic necrosis within the placenta, often due to inadequate blood supply. In the third trimester, this condition can lead to serious complications, including fetal growth restriction, preterm birth, and stillbirth. The clinical presentation may vary based on the extent of the infarction and the underlying causes.
Signs and Symptoms
-
Maternal Symptoms:
- Abdominal Pain: Patients may experience localized or diffuse abdominal pain, which can be a sign of placental issues.
- Vaginal Bleeding: This can occur due to placental detachment or other complications associated with infarction.
- Decreased Fetal Movement: A noticeable reduction in fetal activity may indicate fetal distress, often linked to placental insufficiency. -
Fetal Symptoms:
- Growth Restriction: Infarction can lead to inadequate nutrient and oxygen supply, resulting in intrauterine growth restriction (IUGR).
- Non-Reassuring Fetal Heart Rate Patterns: Abnormalities in fetal heart rate monitoring may suggest compromised fetal well-being.
Diagnostic Indicators
- Ultrasound Findings: Imaging studies may reveal areas of placental necrosis, abnormal placental thickness, or signs of fetal distress.
- Doppler Studies: These can assess blood flow in the umbilical artery, helping to identify placental insufficiency.
Patient Characteristics
Certain patient characteristics may predispose individuals to placental infarction:
- Maternal Age: Advanced maternal age (typically over 35 years) is associated with increased risks of placental complications.
- Medical History: Conditions such as hypertension, diabetes, and clotting disorders can contribute to placental insufficiency and infarction.
- Lifestyle Factors: Smoking, substance abuse, and poor nutrition during pregnancy are significant risk factors.
- Multiple Gestations: Women carrying multiples are at higher risk for placental complications, including infarction.
Conclusion
Placental infarction in the third trimester is a critical condition that requires careful monitoring and management. Recognizing the signs and symptoms, along with understanding patient characteristics, can aid healthcare providers in making timely interventions to improve outcomes for both mother and fetus. Early diagnosis through ultrasound and Doppler studies is essential for managing this condition effectively.
Approximate Synonyms
When discussing the ICD-10 code O43.813, which refers to "Placental infarction, third trimester," it is useful to consider alternative names and related terms that may be encountered in medical literature or clinical practice. Here’s a detailed overview:
Alternative Names for Placental Infarction
-
Placental Ischemia: This term describes a condition where the placenta does not receive adequate blood supply, leading to tissue death (infarction).
-
Placental Necrosis: This refers to the death of placental tissue, which can occur due to insufficient blood flow, similar to infarction.
-
Placental Thrombosis: This term is often used interchangeably with placental infarction, as thrombosis (the formation of a blood clot) can lead to areas of infarction within the placenta.
-
Infarcted Placenta: A more straightforward term that describes a placenta that has experienced infarction.
-
Third Trimester Placental Infarction: While this is a direct reference to the ICD-10 code, it emphasizes the timing of the condition during pregnancy.
Related Terms
-
Fetal Compromise: This term is often used in clinical settings to describe situations where the fetus is at risk due to placental issues, including infarction.
-
Pregnancy Complications: Placental infarction is categorized under complications that can arise during pregnancy, affecting both maternal and fetal health.
-
Placental Insufficiency: This term refers to the placenta's inability to deliver adequate nutrients and oxygen to the fetus, which can lead to infarction.
-
Antepartum Hemorrhage: While not synonymous, this term can be related as placental infarction may contribute to bleeding before labor.
-
Maternal-Fetal Medicine: This specialty often deals with conditions like placental infarction, focusing on high-risk pregnancies.
-
Obstetric Complications: A broader category that includes various issues during pregnancy, including placental infarction.
Conclusion
Understanding the alternative names and related terms for ICD-10 code O43.813 is essential for healthcare professionals, as it aids in accurate diagnosis, documentation, and communication regarding placental health during pregnancy. These terms can also enhance clarity when discussing patient cases or conducting research related to placental conditions.
Diagnostic Criteria
The diagnosis of placental infarction, particularly in the third trimester, is associated with the ICD-10-CM code O43.813. Understanding the criteria for this diagnosis involves recognizing the clinical features, diagnostic methods, and relevant guidelines.
Clinical Features of Placental Infarction
Placental infarction refers to localized areas of ischemic necrosis within the placenta, which can occur due to various factors, including maternal hypertension, diabetes, or vascular disorders. The following clinical features are often considered in the diagnosis:
- Maternal Symptoms: Patients may present with symptoms such as abdominal pain, vaginal bleeding, or fetal distress. However, some cases may be asymptomatic, making careful monitoring essential[1].
- Fetal Monitoring: Abnormal fetal heart rate patterns may indicate placental insufficiency, prompting further investigation[1].
Diagnostic Methods
The diagnosis of placental infarction typically involves several diagnostic approaches:
-
Ultrasound Examination:
- Sonographic Findings: Ultrasound is the primary imaging modality used to assess placental health. Findings suggestive of placental infarction may include:- Areas of decreased echogenicity within the placenta.
- Abnormal placental morphology or thickness.
- Evidence of fetal growth restriction, which may indicate compromised placental function[1][2].
-
Histopathological Examination:
- In cases where placental tissue is available (e.g., after delivery), histological examination can confirm the presence of infarcts. This involves identifying areas of necrosis and assessing the extent of vascular compromise[2]. -
Maternal and Fetal Assessment:
- Comprehensive evaluation of maternal health, including blood pressure monitoring and screening for conditions like preeclampsia, is crucial. Additionally, fetal assessments through non-stress tests or biophysical profiles may be performed to evaluate fetal well-being[1][2].
Coding Guidelines
According to the ICD-10-CM coding guidelines, the specific code O43.813 is used for placental infarction diagnosed during the third trimester. The criteria for coding include:
- Timing of Diagnosis: The diagnosis must be confirmed during the third trimester of pregnancy, which is defined as weeks 28 to 40[1].
- Documentation: Accurate documentation in the medical record is essential, including the clinical findings, diagnostic imaging results, and any relevant maternal or fetal assessments that support the diagnosis[1][2].
Conclusion
In summary, the diagnosis of placental infarction (ICD-10 code O43.813) in the third trimester relies on a combination of clinical features, imaging studies, and, when applicable, histopathological confirmation. Proper documentation and adherence to coding guidelines are crucial for accurate diagnosis and treatment planning. If you have further questions or need more specific information, feel free to ask!
Related Information
Treatment Guidelines
- Ultrasound evaluation for placental infarction assessment
- Fetal heart rate monitoring to detect distress signs
- Control of maternal health issues like hypertension or diabetes
- Nutritional support for balanced diet and fetal development
- Corticosteroids for accelerating fetal lung maturity in preterm delivery cases
- Anticoagulation therapy for improving placental blood flow with clotting disorders
- Adjusted timing of delivery based on severity of placental infarction and fetal health
Description
- Localized areas of ischemic necrosis in placenta
- Resulting from inadequate blood supply to placenta
- Compromised placental blood flow due to maternal conditions
- Thrombosis or embolism in maternal or fetal circulation
- Certain infections contributing to placental dysfunction
- Abnormal fetal heart rate patterns and decreased fetal movement
- Signs of maternal distress including abdominal pain or bleeding
Clinical Information
Approximate Synonyms
- Placental Ischemia
- Placental Necrosis
- Placental Thrombosis
- Infarcted Placenta
- Third Trimester Placental Infarction
Diagnostic Criteria
- Localized areas of ischemic necrosis in placenta
- Maternal hypertension a contributing factor
- Diabetes may cause placental infarction
- Abdominal pain and vaginal bleeding symptoms
- Fetal distress and growth restriction
- Ultrasound findings: decreased echogenicity
- Ultrasound findings: abnormal morphology or thickness
- Histopathological examination confirms necrosis
- Timing of diagnosis in third trimester (28-40 weeks)
- Accurate documentation essential for coding
Related Diseases
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.